Alnylam Receives Grant of New Patent Broadly Covering RNAi Therapeutics (Business Wire via Yahoo! Finance)

Alnylam Receives Grant of New Patent Broadly Covering RNAi Therapeutics (Business Wire via Yahoo! Finance)
CAMBRIDGE, Mass.—-Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today the first grant for the Kay & McCaffrey patent. The patent is an early, “fundamental” patent in the RNAi therapeutics field based on the groundbreaking research by Drs.